The Yankees' Bench Battle: Paul DeJong's Comeback Story
In a surprising move, the New York Yankees have signed veteran infielder Paul DeJong to a minor league deal, as reported by Jon Heyman of the New York Post. This development adds an intriguing layer to the Yankees' already stacked roster, but it's a story that goes beyond just the signing.
DeJong, now 32, has had a rollercoaster ride in his MLB career. Drafted by the St. Louis Cardinals in 2015, he quickly rose through the minor league ranks and made his MLB debut in 2017. His power-hitting abilities were evident from the start, with 25 home runs in just 108 games, earning him a second-place finish in the NL Rookie of the Year voting that season. This impressive performance led the Cardinals to lock him down with a long-term contract, a six-year extension that seemed like a promising future.
But here's where it gets controversial... DeJong's journey took a turn. Despite a few solid years as a league-average hitter, his offensive numbers began to decline, especially during the shortened 2020 season. A brief resurgence in 2023 wasn't enough to keep him with the Cardinals, and he was traded to the Blue Jays. Unfortunately, his performance in Toronto and San Francisco was abysmal, and his value took a significant hit.
And this is the part most people miss... DeJong's free agency prospects have been challenging. Despite decent seasons with the White Sox and later the Nationals, he's found himself signing with rebuilding teams, and his contracts have been less than stellar. Last year's $1MM guarantee with the Nationals was even lower than his previous deal, and an unfortunate injury further derailed his season.
Now, DeJong finds himself with the Yankees, competing for a bench spot in a crowded mix. With players like Amed Rosario and J.C. Escarra already securing bench roles, DeJong will have to battle it out with Oswaldo Cabrera, Jorbit Vivas, and Braden Shewmake for the remaining spots. The Yankees' bench situation is further complicated by potential roster additions and the return of injured players, making DeJong's path to the roster even narrower.
So, will DeJong make the cut? Only time will tell. With injuries and trades always a possibility, DeJong might just find his role with the Yankees. It's a comeback story worth following, and we can't wait to see how it unfolds.
What do you think? Is DeJong's signing a smart move by the Yankees? Or is it a risky gamble? Let us know your thoughts in the comments!
